Related Experiment Video
Updated: Oct 10, 2025

08:47
Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
3.2K
Esterase D stabilizes FKBP25 to suppress mTORC1
Yuejun Yang1, Xinpeng Chen1,2, Wen Yao1
1Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Science, Shandong University, Qingdao, 266237, People's Republic of China.
Cellular & Molecular Biology Letters
|December 8, 2021
Summary
Esterase D (ESD) stabilizes FKBP25 by reducing its ubiquitination, inhibiting mTORC1 signaling and suppressing tumor cell growth via autophagy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Esterase D (ESD) is an enzyme involved in formaldehyde detoxification.
- ESD's role in physiological and pathological processes is recognized, but its signaling pathway is not well understood.
Purpose of the Study:
- To investigate the molecular mechanism of Esterase D (ESD).
- To identify proteins interacting with ESD and elucidate its signaling pathway.
- To evaluate the effect of an ESD activator (FPD5) on cancer cell viability.
Main Methods:
- Yeast two-hybrid assay and co-immunoprecipitation (CO-IP) to identify ESD interacting proteins.
- Western blot to analyze phosphorylation of mTORC1 pathway components.
- Sulforhodamine B (SRB) and chick chorioallantoic membrane (CAM) assays to assess cell viability.
Main Results:
- FK506 binding protein 25 (FKBP25) was identified as an interacting protein with ESD, with the N-terminus of FKBP25 being crucial for interaction.
- ESD reduces K48-linked poly-ubiquitination of FKBP25, leading to its stabilization.
- ESD suppresses mTORC1 activity and inhibits tumor cell growth in vitro and in vivo through autophagy.
Conclusions:
- The study elucidates a novel molecular mechanism involving ESD and FKBP25 ubiquitination.
- The ESD/FKBP25/mTORC1 signaling pathway regulates autophagy and inhibits cancer cell proliferation.
- These findings offer insights into targeting this pathway for cancer therapy.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
4.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
MAPK Signaling Cascades
6.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
The Unfolded Protein Response
5.2K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.2K
Amplifying Signals via Enzymatic Cascade
13.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
13.3K
Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K

